FDA Announces Final Guidance for Formal Meetings with OTC Monograph Drug Sponsors

Summary

The Food and Drug Administration (FDA) has released a final guidance document outlining procedures for formal meetings between the agency and sponsors or requestors of over-the-counter (OTC) monograph drugs, which will help ensure compliance with the Federal Food, Drug, and Cosmetic Act (FD&C Act).